| DELCATH SYS NEW DL-,01 |
| USA |
| Gesundheit |
| US24661P8077 / A2PT5P |
| DV3R (Frankfurt) / DCTH (NASDAQ) |
| FRA:DV3R, ETR:DV3R, DV3R:GR, NASDAQ:DCTH |
| - |
| http://delcath.com/ |
|
Delcath Systems Inc. is a medical device company focused on providing treatment options for primary and metastatic liver cancers through its innovative technologies. Central to their product offerings is the percutaneous hepatic perfusion (PHP) syste..
>Volltext.. |
| 287.16 Mio. EUR |
| 210.49 Mio. EUR |
| 73.84 Mio. EUR |
| 0.87 Mio. EUR |
| 2.34 Mio. EUR |
| 0.07 EUR |
| 0.81 Mio. EUR |
| 37.64 Mio. EUR |
| 19.51 Mio. EUR |
| 8.31 |
| 101.92% |
| - |
| - |
| - |
| - |
| DELCATH |
| 04.04.26 |
|
||||
|
||||
|
||||
|
||||
|